No news that I’ve heard. But Geron is alive and kicking.

I’ll buy that. Maybe it’s just easier to be a crook when your victims don’t have faces.

I get it now. :)

I was pretty naive about the Greek business culture when I first got involved with Box Ships. Had I understood who Michael Bodouroglou was I would never have gotten involved with this company. For a guy like him, if you don’t have to look a man in eye, it’s not stealing.

BTW I’m not Travis.

How about this for an idea. Bodouroglou Wakes up one morning with a Conscience, sells All Seas to Box Ships for what is owed. Effectively doing a no cost IPO of All Seas. As the prime stock holder he’d make a mint and the rest of use might recover some of our losses.

If he has a deal cooking, he’d be bound by a non disclosure agreement. If he doesn’t then there’s nothing to talk about.

Janson dropped out of the trial. Geron now owns the drug outright. And is continuing the trial on its own.

Nondisclosure agreements can be powerful things.

TEUFF going dark my be indicative of the sticker changing hands as a shell.
There may still be hope for those of us who are in for the duration.
This may be a curtain call but the fat lady is yet to take the stage.
Just my opinion. GLTUA

3 bitcoin a day. 10 a day by August if the price remains stable, plus dash. This stock has to break out soon.

$12 A share, that will give me $120k on $27k invested. I’ll take it.
“That’ll do pig”.

People of Hashchain.

We are all investors in a great company with a bright future. But the activity on this board is anemic to say the least. If we can generate a significant number of posts per day we can get ourselves on the breakout board. If you have an interest in this company please Post. Even if it’s just to say hi.

Thanks, and good luck to us all.

Sound advice. I’ll take the matter in hand. I’m off to work have a great evening thanks for the quick responses.

I get it. I just wish my other investment which puts out positive and reliable news on a regular basis could generate a similar amount of chatter.

I’m referring to attention, in terms of the number of daily posts on iHub.

I’ve been with TEUFF since 2011. When it was an it was an $8 stock paying a 20% dividend. 7 years later I’m into it for 95k and a 3% stake. As long as there’s a heartbeat there’s hope. Putting ships back on line would cause this ticker to skyrocket, at least initially. If current management were still involved, I would take my money and run at the first opportunity. However even the shell has value. Anything that removes the current management from the equation would be better for any long term investor.

Any move towards a productive business activity and this ticker will come alive. I’m in so deep that in only makes sense to wang in for as long as it takes.

Empty but not dead. Ripe for the filling.

I agree with 90% of what you just said. However any buy out will be priced as a function of the value that Imetelstat represents. The Geron board is not obliged to except an early offer at a lower price just because JNJ makes it. If the board is confident of approval it is their fiduciary responsibility to either demand a price indicative of that approval or wait for approval to be completed and then negotiate the price. A buyout predicated on the price of Geron stock at the time of the negotiation is the financial equivalent of the tail wagging the dog. Insiders negotiate based on projected future value. And when the results of that negotiation is made public the stock price responds accordingly. That’s the dog wagging the tail. We are the tail, the Geron and JNJ boards are the dogs.

Have some patience. If aspirin were invented today it would take a decade to get FDA approval. The FDA a is a bureaucracy. You can legitimately criticize the process but nonetheless even a fast track drug will take time to go through the process. FDA approval is unlikely to happen before 2019 or 2020. Unfortunately the fact that lives will be lost in their interim will only factor in to it not taking until 2025 or later. IMHO

My read on JNJ is that they will value any buyout on imelestate not GERN share price.

The GERN share price is of no concern to JNJ. IMHO, they will not execute a buyout until FDA approval is imminent. And they will value it on projected future revenue from imelestate, not GERN share price. Price fluctuations of GERN are not JNJ’s problem, it’s ours.

7 megawatts of electricity will cost something on the order of $8 million per year. Can anybody help me with the math needed to calculate how many coin can be mined with that? We know that they intend to focus on more profitable coin than Bitcoin, but even a hypothetical Bitcoin number would be useful.

Johnson and Johnson has espoused a policy of NOT operating the company with a focus on shareholder value.
The argument being, that if they focus on the needs of customers, partners, employees and the communities that they do business in, shareholders will do just fine. With an average 11% total return over 130yrs, it’s hard to argue.

That being said, the impact that the timing of the continuation grant might have on GERN’s stock price is immaterial from JNJ’s prospective. If Geron is not in immediate need of cash to continue trials, way would JNJ give the grant early? And why would JNJ commit to a merger prior to FDA approval, unless a third party forces there hand?

Stocksinvester, Bigtimebuyguy, and Dr_biotechguru5, thanks for the feedback, this is helpful for me.

Can someone on this board help me out with this. I am a relatively unsophisticated investor with a small steak in Geron. From my readings it seems that both JNJ and Jensen both have some control of the Imetelsate patents already. Enough so that a buy out by another major player would not be practical. And therefore wouldn’t JNJ just simply wait for final FDA approval to exercise a buyout? Which probably will not be for several years. And considering how deeply involved they are already with Geron, wouldn’t the price for that buyout have been agreed to several years ago?

To the long time shareholders of TEUFF. There are rumors of foot. The management of Box Ships may have reason to begin behaving in a manner more aligned with the interests of the common shareholder. Keep the faith and GLTUA.

And a marvelous home it could be.

One of the few good points made by “ He Who Shall Not Be Named”, is that the current pps represents little opportunity the rise capital. The only way to change that is to present a working business plan. One that includes ships. Based on the previous sustained high pps, each ship added would represent +/- $1.00 per share. Let all wish successes to our activist brethren in there efforts to achieve just that.

Assuming that all the recent PR, and the positive projections based on that PR are valid. Then the longer JNJ waits to execute a buyout the more expensive it will be. IMHO I feel the longs will be far better served if said buyout is held off to 2019 or 2020. A buyout now would only serve to dilute the value of this new drug over the entirety of the JNJ market cap.

The shorts are in the panic mode. And the traders are taking profit. This is a long play. I’m only in for 10 K at $2 so it’s all or nothing for me.

Buyout at $62.80 by 2020? Hay, I can dream can’t I.

With in 30 day IMHO.

I love the way you think.

GLTUA

It’s an empty shell, and a reverse split dose not a full shell make.

There’s no financing available because there’s no faith in the company. Gratuitously wiping out current shareholders would do nothing to generate that faith in future investors.

It may be that your skepticism arises from spending too much of your time and energy living in the pennystock universe.

I work for a publicly traded corporation that generates billions of dollars in revenue every month. The vast majority of us who have dedicated our lives to this corporation work tirelessly to provide a quality service with the safety of the public as our primary concern. Even if that public perceives otherwise.

This company just doesn’t have a high enough profile. The minimal activity on this board demonstrates that fact. There are extremely active boards for companies in the crypto currency realm that have no operations no revenue and big promises.

Continuing operations and positive revenue should eventually bring more interest to this company. And I have very positive feelings for the future of this enterprise.

OK, I’ll concede that repetitive reversed splits is a strategy practiced by swindlers, past, present, and future. But as the previous reverse split demonstrated without a viable business plan the exercise did little to either increase the share price or raise capital. I’ve never said that the board will present such a plan but that they should and if they did it would likely be a much more successfulboth for them and us.

As it stands right now the “whales“ control enough aggregate shares to block another reverse split. Leaving the only course of action for the CEO to move forward is to present a business plan and find enough outside capital to commence at least limited operations. Again I’m not saying he will but that he should. If he refuses at least we’ve created a barrier barrier to further malfeasance. I very much would like to recover my investment and even get a positive return myself. However I don’t mind doing my small bit to block further larceny.

While it’s true that some people get rich by cheating their fellow man. Truth is that the vast majority of the worlds wealth has been generated by honest and ethical business practices.

Ok, this is my fourth and final attempt. Just the numbers this time.


It my be noted that a 50 for 1 reverse split was executed just over a year ago. Box ships currently has 475,000,000 authorized, with only 31,153,901 in issue, leaving 443,846,099 available. A reverse split does not typically increase the authorized share amount. So an additional 50 for 1 reverse split would only increase the free shares by 30,530,832 to 474,376,921 or 6.9%. If the authorized shares were to be increased by a factor of 50 that would be 23,750,000,000. I suspect that that figure would horrify any potential future investor.

As for the preferred shares. The only claim they have is to a percentage of future earnings. It’s a debt not due. And a reverse split does nothing to alter that structure.

Yes, they need to present a business plan to increase the share price. A reverse split with out a business plan accomplishes nothing. Except that it would satisfy both your and their belief that wiping out the commons shareholders is how it’s always done and should be done. Again 300 million shares with a marketable business plan would provide more than enough capitalization. And I still believe capital could be raised even without the dilution that 300 million shares represent.